Monday, September 26

03:30 PM - 04:30 PM

K01 - Opening Remarks and Keynote Lecture


K01.01 - Opening Remarks

  Sheila Krishnadath

K01.02 Keynote Lecture  Precision and Personalised Oncology for Esophageal Cancer

  Ken Kato

04:45 PM - 05:45 PM

JS01 - JES Guideline on Oncologic Treatment for Esophageal Cancer (ISDE, JES)


Ken Kato Dr., National Cancer Centre Hospital

JS01.01 - Updates in JES Guidelines on Medical Oncology

  Takahiro Tsushima

JS01.02 - Does Updated JES Guideline Influence on Clinical Practice in Korea?

  Min Hee Hong

JS01.03 - Is New JES Guideline Applicable to Clinical Practice in France?

  Jean-Philippe Metges

04:45 PM - 06:15 PM

PL01 - Trauma, Caustic Injury and Perforation of the Esophagus


  Jari Räsänen   Toni Lerut

PL01.01 - Endoscopic Treatment and Factors Affecting Mortality of Esophageal Perforation

  Peter Siersema

PL01.02 - Is Surgery Still a Valid Option in the Treatment of Boerhaave's Syndrome?

  Jari Räsänen

PL01.03 - Esophageal Stricture After Caustic Injury: Dilatation or Surgery?

  Chadin Tharavej

PL01.04 - Traumatic Perforation of the Esophagus: Diagnosis and Treatment

  Bas Wijnhoven

PL01.05 - Resection and Reconstruction Techniques After Caustic Injury to the Esophagus

  Ivan Cecconello

PL02 - Early Esophageal Cancer: Epidemiology, Methods of Detection and Endoscopic Staging


  Rebecca Fitzgerald   Yin-Kai Chao

PL02.02 - Identification of High-risk Cohorts: Screening, Breath Test, Cytosponge and Methods for Early Diagnosis

  Rebecca Fitzgerald

PL02.03 - Screening Programs in High-incidence Regions, ALDH2 in Asia

  Yin-Kai Chao

PL02.04 - Techniques in Endoscopic Early Detection of Esophageal Neoplasm

  Takuji Gotoda

PL02.05 - Endoscopic Resection as Staging Procedure for Early Esophageal Cancer

  Stefan Seewald

OA01 - Oral Abstracts 1


OA01.01 - Laparoscopic Total Fundoplication is Superior to Medical Treatment for Reducing the Cancer Risk in Barrett's Esophagus: a Long-term Analysis

  Sergio Szachnowicz

OA01.02 - Endoscopic Reference Score Remodeling Subscore and Esophageal Eosinophil Count Do Not Correlate in Placebo-Treated Eosinophilic Esophagitis Patients From Dupilumab Studies

  Ikuo Hirano

OA01.03 - Laparoscopic Cardioplasty for Failed Primary Treatment of Achalasia

  Reda Ezz

OA01.04 - Operative Outcomes of Robotic Gastropexy in the Treatment of Giant Paraesophageal Hernia in Patients with Predominantly Obstructive Symptoms

  Fahim Habib

OA01.06 - Oesophageal Perforations: Causes, Management, and Outcomes at a Specialist Upper Gastrointestinal Unit over a Ten-year Period

  Teri Toi

OA01.07 - Does Postoperative Non-Invasive Ventilation Increase the Risk for Complications in Children Post-Repair of Esophageal Atresia?

  Maye Zheng

OA01.08 - Role of Preoperative Neoadjuvant Chemoradiotherapy for Locally Advanced Borderline Resectable Thoracic Esophageal Cancer

  Akiyuki Wakita

OA01.09 - Risk Factors Associated with Not Receiving Adjuvant Chemotherapy for Locally Advanced Esophagogastric Adenocarcinoma

  Jakub Chmelo

VA01 - Video Abstracts 1


05:45 PM - 06:45 PM

VA01.01 - Thoraco-Laparoscopic Excision of a Foregut Duplication Cyst with a Pyloro-duodenal Communication

  Suraj Surendran

VA01.02 - Alport Syndrome with Esophageal Leiomyoma Treated with Conservative Distal Robotic Myotomy: Avoiding Esophagectomy?

  Flavio Roberto Takeda

VA01.03 - Epiphrenic Diverticulum Causing Gastroesophageal Junction Outflow Obstruction (EGJOO)

  Xin Yan Lim

VA01.04 - Redo Laparoscopic Heller’s Cardiomyotomy

  Shankar Balasubramanian

VA01.05 - Thoracoscopic Enucleation of Giant Oesophageal Leiomyoma

  Inian Samarasam

VA01.06 - Thoracolaparoscopic Excision of Esophageal Duplication Cyst

  Parthasarathi Ramakrishnan

VA01.07 - VATS Esophageal Diverticulectomy with Laparoscopic Heller Myotomy and Dor Fundoplication

  Siu Hong Cheung

VA01.09 - Management of Intraoperative Tracheal Tear during Esophagectomy

  Subramanyeshwar Rao Thammineedi

VA01.08 - Robotic Esophageal Leiomyoma Enucleation

  Sabita Jiwnani

JS02 - JES Guideline on Endoscopic Treatment for Esophageal Cancer (ISDE, JES)


  Ryu Ishihara

06:30 PM - 08:00 PM

JS02.01 - Updates in JES Guideline on Endoscopic Treatment for Esophageal Cancer

  Tomohiro Kadota

JS02.02 - Is New JES Guideline Applicable to Endoscopic Treatment in Hong Kong?

  Hon Chi Yip

JS02.03 - Esophageal Submucosal Adenocarcinoma: Work-up and Post-endoscopic Resection Management

  Jacques Bergman

PL03 - The Tapestry of Reflux Syndromes


  David Watson   Peter Kahrilas

PL03.01 - Cost-effective Diagnosis of GERD

  Peter Kahrilas

PL03.02 - Diagnosis of Symptomatic Non-acidic Gastroesophageal Reflux

  Arjan Bredenoord

PL03.03 - Reflux in the Obese and Post-bariatric Procedures

  André Brandalise

PL03.04 - GERD in East and West - Is There a Difference in Management?

  Jimmy So

PL03.05 - Surgical Treatment of GERD, Fundoplication and Other Techniques - the Right Procedure for the Right Patient

  David Watson

PL04 - Recent Topics in Endoscopic Treatment for Esophageal Cancer


  Michael Bourke   Takuji Gotoda

PL04.01 - Extended Indications for Endoscopic Resection of Adenocarcinoma

  Michael Bourke

PL04.02 - Ablation and Surveillance of pT1b Patients Treated With Endoscopic Resection

  Roos Pouw

PL04.03 - Barrett’s Neoplasia: New Treatment Modalities

  Jacques Bergman

PL04.04 - Use of Stent Before Curative Esophagectomy: Should This Be Done?

  Guillaume Piessen

PL04.05 - Prevention of Stricture after ED for Widespread ESCC

  Chika Kusano

OA02 - Oral Abstracts 2


OA02.02 - The Modality of Neoadjuvant Versus Adjuvant Chemoradiotherapy for Locally Advanced Esophageal. Carcinoma: A Single Center, Randomized, Clinical Trial

  Liu Kun

OA02.03 - Assessment of Tumor Regression Grade in Esophageal Squamous Cell Carcinoma After Chemoradiotherapy: Comparison of 3 Commonly Used Scoring Systems

  Shih-han Huang

OA02.05 - The Primary Tumor Burden Score: A Novel Clinicopathological Staging Tool for Patients with Esophageal Carcinoma Receivnig Neoadjuvant Chemoradiotherapy Plus Surgery

  Xu Huang

OA02.06 - Radiofrequency Ablation of Low-Grade Dysplasia is Cost-Effective for Patients with Long-Segment Barrett's Oesophagus

  Ravi Vissapragada

OA02.07 - Do Patients with "Early" Esophageal Cancer Need Neoadjuvant Therapy?

  Karthik Venkataramani

OA02.08 - Clonal Relationship and Alcohol Consumption-Associated Mutational Signature in Synchronous Hypopharyngeal Tumors and Esophageal Squamous Cell Carcinoma

  Josephine Ko

OA02.09 - Surgical Treatment of Stage IV Esophageal Cancer after CCRT Improves Survival

  Hu-lin Christina Wang

OA03 - Oral Abstracts 3


07:00 PM - 08:00 PM

OA03.01 - Clinical Utility of ctDNA in Longitudinal Monitoring of Treatment Responses and Relapse in Metastatic Esophageal Squamous Cell Carcinoma

  Hoi Yan Ng

OA03.02 - Outcome of Esophageal Resection in Patients with Esophageal Cancer with Histopathologically Confirmed Distant Metastasis

  Elena Atanasova

OA03.03 - Clinical Outcome of Nivolumab Combination Therapy As 1st Line Treatment for Esophageal Cancer in a Japanese Hospital (CheckMate 648)

  Tomoki Makino

OA03.04 - Diversity of Perineural Invasion and Their Predictive Role in Prognosis of Esophageal Squamous Cell Carcinoma

  Jianfei Zhu

OA03.05 - Molecular Subtyping of Esophageal Adenocarcinoma by Non-negative Matrix Factorization of Laser Capture Microdissected RNA-Seq Samples

  Jonathan Yeung

OA03.06 - Establishing a Mass Spectrometry Based Diagnostic Test for Oesophageal Cancer

  Marisa Duong

OA03.07 - The Prognostic Effect of Pathological Lymph Node Regression after Neoadjuvant Chemotherapy for Oesophageal Adenocarcinoma – a Multicentre Study

  Jonathan Moore

OA03.08 - Genomic Alterations and Survival After Treatment of EAC by Surgery Without Chemo- or Radiotherapy

  Reginald Lord

OA03.09 - The Effectivity of Neoadjuvant Chemoradiotherapy in Esophageal Adenocarcinoma with Presence of Extracellular Mucine, Signet-ring Cells or Poorly Cohesive Cells

  Maria Joanna Valkema

JS03 - JES Guideline on Surgical Treatment for Esophageal Cancer (ISDE, JES)


  Yuko Kitagawa

08:15 PM - 09:45 PM

JS03.01 - Updates in JES Guidelines on Surgical/Perioperative Treatment

  Satoru Matsuda

JS03.02 - Does Updated JES Guideline Influence on Clinical Practice in Hong Kong?

  Ian Wong

JS03.03 - Is New JES Guideline Applicable to Clinical Practice in the United States?

  Daniela Molena

PL05 - Functional Complications After Esophageal Surgery


  André Brandalise   Roos Pouw

PL05.01 - Gas-bloat Syndrome After Antireflux Surgery

  André Brandalise

PL05.02 - Transition to Adult Care After Treatment for Esophageal Atresia

  Christophe Faure

PL05.03 - Strictures After Esophagectomy With Gastric Pull-up

  Roos Pouw

PL05.04 - Delayed Gastric Emptying After Esophagectomy

PL05.05 - Barrett's Esophagus After Esophagectomy: a Cause for Concern?

  Prateek Sharma

PL06 - Surgical Approach for Esophageal and EGJ Tumors


  Richard van Hillegersberg   Suzanne Gisbertz

PL06.01 - EGJ Tumors: Optimal Surgery in the East

  Hideaki Shimada

PL06.02 - EGJ Tumors: Optimal Surgery in the West

  Suzanne Gisbertz

PL06.03 - Paraaortic Lymph Node Dissection for Siewert Type II and III EGJ Tumors

  Paul Magnus Schneider

PL06.04 - Current Evidence and/or Ongoing RCT of Minimal Invasive Esophagectomy for Cancer

  Hiroya Takeuchi

PL06.05 - Does MIE Affect the Prognosis of Esophageal Cancer

  Guillaume Piessen

VS01 - Minimally Invasive Approach to Esophagectomy


  C S Pramesh   Riccardo Rosati

VS01.01 - Uniportal Esophagectomy

  Jang-Ming Lee

VS01.02 - Trans-mediastinoscopic Esophagectomy

  Yasuyuki Seto

VS01.03 - Robotic Esophagectomy

  Daniela Molena

VS01.04 - Robotic Transhiatal Dissection

  Rubens Sallum

VS01.05 - VATS Esophagectomy in Semi-prone Position

  Long-Qi Chen

VS01.06 - Thoracoscopic Esophagectomy With Radical Lymphadenectomy

  C S Pramesh

FA01 - Featured Abstracts 1


  John Reynolds   Xing Gao

FA01.01 - Refusing Surgery After Neoadjuvant Treatment in Patients With Esophageal Cancer: A Propensity-Score Matched Survival Analysis

  Chun-Ling Chi

FA01.02 - Malnutrition Defined by GLIM Criteria Associates With Increased Risk of Adverse Outcome After Oesophago-Gastric Cancer Surgery

  Lisa Murnane

FA01.03 - Long Term Risk for Progression to Neoplasia for Barrett’s Esophagus Patients With Validated Low-grade Dysplasia or Indefinite for Dysplasia

  Peter Elbe

FA01.04 - Phase III Comparative Study of Preoperative Treatment of Esophageal Cancer (JCOG1109) – Site of Recurrence and Prognosis of non-pCR Patients

  Takashi Ogata

FA01.06 - Outcomes of Adjuvant Local Treatment after Esophageal Surgery with Positive Resection Margin in Intrathoracic Anastomosis

  Jongbae Son

FA01.08 - The Associated Risk Between Single Nucleotide Polymorphisms of AP1S1 and Esophageal Squamous Cell Carcinoma in Chinese Population

  Su Feng

FA01.09 - Outcome of Neoadjuvant Chemoradiotherapy plus Surgery for Esophageal Squamous Cell Carcinoma in East Asia versus Western Europe

  Xing Gao

OA04 - Oral Abstracts 4


10:00 PM - 11:30 PM

OA04.01 - The Prognostic Value and Molecular Properties of Tertiary Lymphoid Structures in Esophageal Squamous Cell Carcinoma

  Jing Wen

OA04.02 - The Prognostic Impact of Tumor Budding in Esophageal Adenocarcinoma

  Roberto Fiocca

OA04.05 - FDG PT-CT Metabolic Tumour and Nodal Response as a Predictor of Pathological Response and Survival in Patients with Oesophageal Adenocarcinoma

  Jonathan Moore

OA04.06 - The Need for Information and Support in Decision-making in Patients with Esophageal Cancer who Prefer Standard Surgery or Active Surveillance

  Charlène J. Van Der Zijden

OA04.07 - Surgeon’s Behavior Steering Patients to Participate in a Cluster Randomized Trial on Active Surveillance for Esophageal Cancer

  Charlène J. Van Der Zijden

OA04.09 - Endoscopic Scoring System for Achalasia Pre and Post Lower Esophageal Sphincter Intervention: The Delayed Esophageal Clearance in Achalasia (Deca) Score

  Ashton Ellison

PL07 - Debates in Controversies in Esophageal Cancer


  John Reynolds   Magnus Nilsson

PL07.01 - Thoracic Duct Resection in Esophagectomy: Should It Be Done? - Pro

  Hiroya Takeuchi

PL07.02 - Thoracic Duct Resection in Esophagectomy: Should It Be Done? - Con

  Magnus Nilsson

PL07.03 - Does Surgery Have a Role in T4 Disease for Esophageal Cancer? - Pro

  Bas Wijnhoven

PL07.04 - Does Surgery Have a Role in T4 Disease for Esophageal Cancer? - Con

  Florian Lordick

PL07.05 - Can Definitive CRT Replace Esophagectomy? - Pro

  Ken Kato

PL07.06 - Can Definitive CRT Replace Esophagectomy? - Con

  Daniela Molena

PL07.07 - Neoadjuvant Chemoradiotherapy Is Optimum Standard for Esophageal Adenocarcinoma - Pro

  John Reynolds

PL07.08 - Neoadjuvant Chemoradiotherapy Is Optimum Standard for Esophageal Adenocarcinoma - Con

  Lorenzo Ferri

VS02 - Invited Video Festival


  Riccardo Rosati   Wayne Hofstetter

VS02.01 - Prevention and Treatment of Anastomotic Leak With Endosponge

  Stefan Seewald

VS02.02 - Colonic Interposition

  Ivan Cecconello

VS02.03 - Robotic Recurrent Laryngeal Nerve Lymphadenectomy

  Yin-Kai Chao

VS02.04 - Esophageal ESD Tips and Tricks

  Michael Bourke

VS02.05 - Supercharged Jejunum Replacement of the Esophagus

  Wayne Hofstetter

VS02.06 - Endoscopic Treatment of Esophageal Diverticulum

  Stefan Seewald

VS02.07 - Hybrid Prone-left Lateral Position Esophagectomy With VATS Intrathoracic Anastomosis

  Lorenzo Ferri

VS02.08 - Hybrid Esophagectomy With Open Thoracotomy

  Guillaume Piessen

VS02.09 - Minimally Invasive Ivor Lewis Esophagectomy in Lateral Position

  Simon Law

FA02 - Featured Abstracts 2


  Inderpal Sarkaria   Wen-Tao Fang

FA02.01 - The Effect of Enhanced Recovery After Minimally Invasive Esophagectomy: A Randomized Controlled Trial

  Yaxing Shen

FA02.02 - Comparison of Robotic Assisted Minimally Invasive Esophagectomy vs. Minimally Invasive Esophagectomy: A Propensity Matched Study from a Single High-Volume Institution

  Chigozirim Ekeke

FA02.03 - Does Minimally Invasive Esophagectomy Reduce Postoperative Pulmonary Complications? An International Cohort Study from the Oesophagogastric Anastomosis Audit (OGAA)

  Sivesh Kathir Kamarajah

FA02.04 - Differences in Perioperative Strategies in Esophageal Cancer Treatment in 13 Nordic University Hospitals Call for High-level Evidence Regarding These Practices

  Jakob Hedberg

FA02.05 - Genomic Analysis of Response to Neoadjuvant Chemotherapy in Oesophageal Adenocarcinoma

  Stella P. Breininger

FA02.06 - Prediction of Lymph Node Metastasis in Patients With Esophageal Squamous Cell Carcinoma Using Genetic Signatures From Large-Scale Genomic Repertoires

  Xiaozheng Kang

FA02.07 - Extension of FDG-PET-Based Radiomic Models on Identification of Patients With Residual Esophageal Cancer After Neoadjuvant Chemoradiotherapy

  Maria Joanna Valkema

FA02.08 - Toripalimab Combination With Chemotherapy and Subsequent Radiation in Patients With Stage IV Esophageal Carcinomaa Prospective Phase II Study (TR-EAT Trial)

  Qifeng Wang

FA02.09 - Mapping of Lymph Node Metastasis From Thoracic Esophageal Cancer: A Retrospective Study

  Yafan Yang

OA05 - Oral Abstracts 5


OA05.01 - Surgery Versus Non-surgical Treatment for Thoracic Esophageal Cancer in Patients Older Than 70 Years: A Retrospective Analysis of 749 Cases

  Kexun Li

OA05.02 - Does Chest Pain Affect the Long Term Outcome of Surgery for Esophageal Achalasia?

  Valentina Tassi

OA05.03 - Esophageal Achalasia: Very Long Follow-up Study on Patterns and Complications of Post Myotomy GERD

  Valentina Tassi

OA05.04 - The Tumour Immune Microenvironment in Oesophageal Adenocarcinoma Has Prognostic Significance

  James Lonie

OA05.05 - Robot-assisted Minimally Invasive Thoraco-laparoscopic Esophagectomy versus Minimally Invasive Esophagectomy for Resectable Esophageal Adenocarcinoma: A Randomized Controlled Trial (ROBOT-2-trial)

  Evangelos Tagkalos

OA05.06 - Esophagogastric Junction Cancer: A Difficult Border: A Worldwide Survey on Oncological and Surgical Approach

  Simone Giacopuzzi

OA05.07 - Enhanced Recovery after Surgery for Video-Assisted Thoracoscopic (VATS) Esophagectomy- A propensity score matching analysis in a local institute

  Choi Kwan So

OA05.08 - Left Thoracophrenotomy Oesophagogastrectomy as an Alternative Approach in Oesophageal Cancer

  Ahmed Ammar

OA05.09 - Robotic-assisted Minimally Invasive Esophagectomy (RAMIE): Is This the Way to a More Accurate Thoracic Lymphadenectomy?

  Jacopo Weindelmayer

OA06 - Oral Abstracts 6


OA06.01 - Automated Surgical Step Recognition for Robot-Assisted Minimally Invasive Esophagectomy Using Artificial Intelligence

  Masashi Takeuchi

OA06.02 - Outcomes after Robot-assisted Minimally Invasive Esophagectomy: Review of 1000 Patients in a Single Center

  Yang Yang

OA06.03 - Value of Extended and Total Mediastinal Lymphadenectomy in Esophageal Tumors

  Luis Hurtado Pardo

OA06.04 - Modified en bloc Esophagectomy with Total Lymphadenectomy in Patients with Residual Rumor after Neoadjuvant Chemoradiotherapy for Esophageal Squamous Cell Carcinoma

  Po-kuei Hsu

OA06.05 - Competency Assessment Tool for Minimally Invasive Esophagectomy: Development, Construct Validity, Reliability and Version 2

  Mirte Ketel

OA06.06 - Incidence and Impact of Preoperative Hiatal Hernia in Patients with Esophageal Carcinoma Undergoing Curative Surgical Resection

  Daniel Solomon

OA06.07 - Short-term Clinical Effect of Robot-assisted Esophagectomy with Thoracic Duct Resection

  Chunguang Li

OA06.08 - The Impact of Overall Survival on Two-field or Three-field Lymphadenectomy in Middle and Lower Thoracic Esophageal Squamous Cell Carcinoma

  Kexun Li

OA06.09 - Propensity Score-matched Comparison of Outcomes between Posterior Mediastinal and Retrosternal Routes of Reconstruction following Three-phase Esophagectomy

  Claudia Wong

Tuesday, September 27

06:30 PM - 08:00 PM

CSDE - What are the Optimal Treatment Regimens for Esophageal Cancer


  Long-Qi Chen   Mark Ferguson   Zhen-Tao Yu

CSDE.01 - Introduction from Prof. He, Honorary President of CSDE

  Jie He

CSDE.02 - What is the Best Strategy for Esophageal Cancer in China: Screening, Early Diagnosis, and Treatment

  Wenqiang Wei

CSDE.03 - The Changes in the Surgical Treatment for Esophageal Cancer in China

  You-Sheng Mao

CSDE.04 - Can the Robotic Approach Improve Patient’s Survival in Surgical Treatment of Esophageal Cancer? Mid-term Results of RAMIE Trial

  Zhigang Li

CSDE.05 - Definitive Chemoradiotherapy for Advanced Esophageal Squamous Cell Carcinoma - Results from Multiple Centers in China

  Lv-Hua Wang

CSDE.06 - A Phase II Clinical Trial of Toripalimab Combined with Neoadjuvant Chemoradiotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma (NEOCRTEC1901)

  Jianhua Fu   Rui Chen

CSDE.06 Panel Discussion

  Jun-Feng Liu   Ke-Neng Chen   Wen-Tao Fang   Yin Li

PL08 - Complications After Esophagectomy


  Paul Magnus Schneider   Simon Law

PL08.01 - Chylothorax: Definition and Evidence-based Treatment

  Sivesh Kathir Kamarajah

PL08.02 - Roux-en-y Duodenal Diversion for Prevention and Treatment of Delayed Gastric Emptying Following Esophagectomy

  Masahiko Yano

PL08.03 - Bowel Herniation After Esophagectomy: a Specific Problem of MIE - Prevention and Treatment

  Rubens Sallum

PL08.04 - Anastomotic Leakage and Gastric Conduit Necrosis

  Paul Magnus Schneider

PL08.05 - Recurrent Laryngeal Nerve Injury: Prevention and Management

  Simon Law

PL08.06 - International ESODATA Experience: What Do We Know, Where Do We Go?

  Donald E. Low

PL09 - What is New in Translational Oncology in Esophageal Cancer


  Andrew Barbour   Karyn Goodman

PL09.01 - Scientific Insights Into Tumor Microenvironment: Implications for Therapy

  Andrew Barbour

PL09.02 - Radiation Therapy: New Vistas Incorporating Metabolic Response and Immune Cell Modulation in Multimodal Therapy

  Karyn Goodman

PL09.03 - Role of Patient-derived Organoids in Tailoring Neoadjuvant Therapy

  Lorenzo Ferri

PL09.04 - Circulating Tumor DNA: Current Status, Is It Ready to Change the Paradigm?

  Florian Lordick

PL09.05 - Genomics of Esophageal Cancer: Current Status and Future Prospects

  Hye Ryun Kim

OA07 - Oral Abstracts 7

OA07.02 - Evaluation of Subcarinal Lymph Node Dissection and Metastasis in Transmediastinal Radical Esophagectomy

  Jun Shibamoto

OA07.01 - Robot-assisted and Conventional Minimally Invasive Esophagectomy are Associated with Better Postoperative Results Compared to Hybrid and Open Transthoracic Esophagectomy

  Evangelos Tagkalos

OA07.03 - Clinical Outcomes of Esophagectomy in Advanced Age Patients – A Propensity Score Matching Study in a Local Institute

  Choi Kwan So

OA07.04 - Perioperative Morbidity and Mortality after Standard Two-field and Radical Three-field Esophagectomy – Results from a Randomized Trial

  C S Pramesh

OA07.05 - Near-infrared Fluorescence Imaging of Thoracic Duct in Minimally Invasive Esophagectomy

  Sida Cheng

OA07.06 - Analytic Morphomic Index and Quantitative Gastric Perfusion Assessment for Risk Stratification of Anastomotic Leaks following Esophagectomy

  Yoshitaka Ishikawa

OA07.07 - Determining Severity of Esophageal Anastomotic Leak in Patients After Esophagectomy: Development of the SEAL Score

  Sander Ubels

OA07.08 - Implementation of the Esophagectomy Complications Consensus Group Definitions: The Benefits of Speaking the Same Language

  Duncan Muir

OA07.09 - The Risk Factors of Hiatal Hernia in Esophageal Cancer Patients Who Received Gastric Interposition Through Posterior Mediastinal Route

  Osbert Qi Yao Leow


VA02 - Video Abstracts 2


08:15 PM - 09:45 PM

VA02.01 - How to Do It? Supracarinal Approach of the Left Recurrent Laryngeal Nerve Area for Lymphadenectomy During Thoracoscopic Esophagectomy

  Luis Hurtado Pardo

VA02.04 - Oesophagectomy With Roux-en-Y Double-Tract Recontruction for Distal Oesophageal Cancer

  Jia Jun Ang

VA02.05 - Fully Robotic Ivor-Lewis Esophageal Resection (RAMIE) – Technical Details of the RAMIE Procedure in the ROBOT2 Trial

  Peter Grimminger

VA02.06 - Video Assisted Thoracoscopic Esophagectomy with Aberrant Vascular Anatomy

  Choi Kwan So

VA02.07 - Manual Layer Embedded Anastomosis: A New Technique to Reduce Anastomosis Leakage after Esophagectomy

  Wenwu He

VA02.09 - Preventing Esophago-gastric Anastomotic Leaks; The Role of Load-Bearing Sutures

  Thomas Walsh

PL10 - The Cutting Edge in Reflux and Barrett's Esophagus


  David Watson

PL10.01 - Diagnosis and Treatment of Refractory GERD

  Michael Vaezi

PL10.02 - Novel Endoscopic Treatment of GERD: ARMA, POEF and Others

  Haruhiro Inoue

PL10.03 - Approaches to Esophageal Lengthening: When, How, and Outcomes

  Ines Gockel

PL10.04 - What to Do for Dysphagia and Return of Reflux After Fundoplication

  David Watson

PL10.05 - Endoscopic Management of Benign Recalcitrant Stricture

  Prateek Sharma

PL11 - Immuno-oncology, Targeted Therapies in Treatment of Esophageal Cancer


  Florian Lordick   Satoru Matsuda

PL11.01 - Has Immunotherapy Changed the Clinical Landscape of ESCC

  Satoru Matsuda

PL11.02 - Neoadjuvant Immunotherapy for Esophageal and Esophago-gastric Junction Adenocarcinoma: Scientific Rationale, Current Evidence, and Clinical Trials

  Hye Ryun Kim

PL11.03 - Role of Surgery in Oligometastatic Disease of EGJ Cancer: the Renaissance Trial

  Stefan Moenig

PL11.04 - Molecular Targeted Therapies: Current Status

  Andrew Barbour

PL11.05 - What Is the Appropriate Radiation Field in Esophageal Cancer Treatment?

  Karyn Goodman

VS03 - GERD, Barrett's Esophagus and Benign Pathologies


  Haruhiro Inoue   Mark Ferguson

VS03.01 - TIFF Procedure Dos and Don’ts

  Silvana Perretta

VS03.02 - Giant Hiatal Hernia Repair

  Ewen Griffiths

VS03.03 - Redo Surgery for GERD

  David Watson

VS03.04 - Submucosal Tunnel Endoscopic Resection of Benign Esophageal Lesions

  Haruhiro Inoue

VS03.05 - Endoscopic Incision Therapy for Benign Esophageal Stricture

  Tomohiro Kadota

VS03.06 - Magnifying Endoscopic Diagnosis With NBI or BLI for Barrett's Esophagus

  Prateek Sharma

FA03 - Featured Abstracts 3


  Chadin Tharavej   David Edholm

FA03.01 - Pre-existing Mesh At The Hiatus Increases Morbidity During And After Revisional Antireflux Surgery: A National Cohort Study

  David Liu

FA03.02 - Different Clinical Symptom Patterns in Patients With Reflux Micro-Aspiration Confirmed by New Pulmonary Aspiration Scintigraphy Technique

  Oleksandr Khoma

FA03.03 - Anti-reflux Radiofrequency Therapy Using STRETTA for Refractory GORD Is Feasible and Reduces the Need for Minimally Invasive Surgery

  Abraham Joel

FA03.04 - Laparoscopic Fundoplication Effective in Treating Reflux Micro-Aspiration

  Oleksandr Khoma

FA03.05 - Local Inflammatory Response to Gastroesophageal Reflux: Association of Gene Expression of Inflammatory Cytokines With Multichannel Intraluminal pH-Impedance Data

  Sergey Morozov

FA03.06 - Endoscopic Vacuum Therapy for Patients With Esophageal Perforation: A Multi-Center Retrospective Cohort Study

  Lisanne Pattynama

FA03.07 - Esophageal Perforations – A Population-Based Nationwide Study in Sweden With Survival Analysis

  David Edholm

FA03.08 - Intentional Foreign Body Ingestion Among Adults: An Updated 2022 Systematic Review of Case Report Outcomes and Implications for Endoscopic Management

  Maria-Kassandra Coronel

FA03.09 - New Endoscopic Treatment Technique to Prevent Refractory Corrosive Esophageal Strictures

  Thitiporn Chobarporn

OA08 - Oral Abstracts 8


10:00 PM - 10:45 PM

OA08.01 - Outcome Following Minimal Invasive Versus Open Esophagectomy for Esophageal Carcinoma Patients With Liver Cirrhosis: A Propensity Score-Matched Analysis

  Yi-yu Lin

OA08.02 - Major Intraoperative Complications in Minimally Invasive Esophagectomies

  Henna Söderström

OA08.03 - Quantitative Estimation of Gastric Conduit Perfusion to Select Esophagectomy Patients at High Risk of Impaired Perfusion

  Yoshitaka Ishikawa

OA08.04 - Minimally Invasive Cervical Esophagectomy (MICE): First Results of a Dutch Pilot Study

  L.M. van Veenendaal

OA08.05 - Frailty as a Predictor of Postoperative Complications in Patients Undergoing Esophagectomy

  Sheuli Chowdhury

OA08.06 - Evaluation of the Results of “Tubeless” Esophagectomy in Patients With Esophageal Cancer Within an ERAS Protocol

  Miriam Menéndez Jiménez

OA08.07 - Risk Factors of Delayed Gastric Emptying after Esophagectomy with Gastric Interposition: An Analysis of 810 Cases

  Ming Ru Yu

OA08.08 - Robotic Versus Thoracolaparoscopic Esophagectomy for Carcinoma Esophagus: A Prospective Comparative Study of Pathological Radicality and Short Term Outcomes

  Parthasarathi Ramakrishnan

OA08.09 - Clinical Implications of Chyle Leakage Following Esophagectomy

  Sofie Henckens

P01 - Presidential Lecture

  Population Screening for Esophageal Cancer. How Can We Make It Work?

  Sheila Krishnadath

11:00 PM - 11:59 PM

ESDE - Oligometastatic Disease in Esophageal Cancer: Moving Landscape in the Era of Immunotherapy (part 1)


  John Reynolds   Richard van Hillegersberg

ESDE.01 - Definition and Overview of Oligometastatic Disease in Esophageal Cancer

  Richard van Hillegersberg

ESDE.02 - Oligometastatic Disease in the Era of Immunotherapy and Precision Medicine

  Florian Lordick

ESDE.03 - SBRT and Local Ablative Techniques for Oligometastatic Disease

  Karyn Goodman

PL12 - New Insights into Achalasia (part 1)


  Arjan Bredenoord   Hironari Shiwaku

PL12.01 - Diagnosis of Achalasia According to Chicago 4.0

  John Pandolfino

PL12.02 - Pneumatic Dilation, POEM or Heller's Myotomy?

  Giovanni Zaninotto

PL12.03 - Treatment of Achalasia in Children

  Christophe Faure

FA04 - Featured Abstracts 4 (part 1)


  Camiel Rosman   Hon Chi Yip

FA04.01 - Superior Mediastinal Dissection During Minimally Invasive Esophagectomy for Esophageal Cancer – A Multicenter Propensity Score Matched (PSM) Analysis

  Hon Chi Yip

FA04.02 - Favorable Outcomes of Jejunal Interposition Reconstruction Without Vascular Anastomosis After Esophagectomy for Cancer: A Single-Center Experience Over Two Decades

  Lilan Zhao

FA04.03 - The Effectiveness of Telephone and Internet-Based Supportive Care for Patients With Esophageal Cancer on Enhanced Recovery After Surgery in China

  Yuan Yu

FA04.04 - Treatment of Anastomotic Leak After Esophagectomy (TENTACLE– Esophagus) Study: Efficacy of Different Initial Treatment Strategies for Anastomotic Leak

  Sander Ubels

FA04.06 - Indocyanine Green Fluorescence Angiography versus Visual Assessment for Gastric Conduit Perfusion Assessment in Patients undergoing Esophagectomy: A Randomized Controlled Study

  Subramanyeshwar Rao Thammineedi

OA09 - Oral Abstracts 9 (part 1)


OA09.01 - The Role of Early Mobilization After Esophageal Cancer Surgery

  Nannet Schuring

OA09.02 - Impact of Surgery Start Time on Short Term Outcomes of Elective Esophagectomy for Cancer

  Tzu Yi Yang

OA09.03 - Sarcopenia After Neoadjuvant Chemotherapy Is Associated With Development of Moderate to Severe Post-Operative Complications in Esophagogastric Adenocarcinoma Patients

  James Convill

OA09.04 - Textbook Outcomes for Oesophagectomy: An Evaluation of Oesophagectomy Quality Performance Indicators at a Single High-Volume Australian Oesophagogastric Centre

  Michael Yulong Wu

OA09.05 - Does MIE Reduce Pulmonary Complications in a Real-world Scenario?

  Srinivas Kodaganur Gopinath

OA10 - Oral Abstracts 10 (part 1)


OA10.01 - Long Term Results of Single and Multi-Incision Minimally Invasive Esophagectomy (MIE) for Treating Esophageal Cancer: A Propensity Score Matched Study

  Yung-Hsin Chen

OA10.02 - Survival Impact of Clinical and Nonclinical Reasons for Delay to Esophagectomy after Neoadjuvant CROSS Therapy

  Yatee Dave

OA10.03 - A Nomogram Based on Body Mass Index Changes to Predict Prognosis After Curative Resection of Esophageal Squamous Cell Carcinoma

  Yi-Min Gu

OA10.04 - Exploring the Optimal Starting Age for Esophageal Cancer Screening Based on Data From a Multicenter Populations-Based Cohort and Cancer Registry

  Ru Chen

OA10.05 - Role of Thoracoscopic Hand-sewn Esophago-gastric Anastomosis in 2-stage Totally Minimally Invasive Esophagectomy. Report of 200 Consecutive Cases

  Spyridon Davakis

OA10.06 - Salvage Surgery for Esophageal Cancer: Is It Time To Refine Surveillance Criteria?

  Rand Abdulrahman

Wednesday, September 28

12:00 AM - 12:30 AM

ESDE - Oligometastatic Disease in Esophageal Cancer: Moving Landscape in the Era of Immunotherapy (part 2)


  John Reynolds   Richard van Hillegersberg

ESDE.04 - Surgery for Oligometastatic Disease

  Suzanne Gisbertz

PL12 - New Insights into Achalasia (part 2)


  Arjan Bredenoord   Hironari Shiwaku

PL12.04 - Management of Reflux After Achalasia Treatment

  Arjan Bredenoord

PL12.05 - Recurrent Achalasia After POEM and Heller's Myotomy

  Hironari Shiwaku

FA04 - Featured Abstracts 4 (part 2)


  Camiel Rosman   Hon Chi Yip

FA04.07 - A 10-year Experience With Anastomotic Leaks in Upper Gastrointestinal Surgery

  Charmaine Zhi-Mei Ng

FA04.08 - Postoperative Outcomes of Salvage Esophagectomy After Definitive Chemoradiotherapy and Planned Esophagectomy After Neoadjuvant Chemoradiotherapy

  Jie Pan

FA04.09 - Omission of Routine Pyloric Procedures in Minimally Invasive Esophagectomy: What Is the Impact on Peri-Operative Outcomes?

  Jarlath Bolger

OA09 - Oral Abstracts 9 (part 2)


OA09.07 - Prognostic Comparison of Lymphovascular Invasion and Lymph Node Metastasis in Esophageal Cancer Patients

  Kexun Li

OA09.08 - Impact of Weekend Effect on Short- and Long-term Survival of Patients Undergoing Esophagectomy for Cancer: A Population-Based, Propensity Score-Matched Analysis

  Tzu Yi Yang

OA09.09 - Long-Term Quality of Life After Minimally Invasive Esophagectomy for Esophageal Cancer: A Single Center Experience

  Amy Jones

OA10 - Oral Abstracts 10 (part 2)


10:00 PM - 11:30 PM

OA10.07 - Real-time Novel Oxygen Saturation Imaging Device to Evaluate the Optimal Anastomotic Site During Thoracic Esophagectomy

  Takeo Fujita

OA10.08 - Single-Port Mediastinoscopic Lymphadenectomy in the Upper and Middle Mediastinum Using Continuous Intraoperative Nerve Monitoring

  Hitoshi Fujiwara

OA10.09 - The Utility of Tissue Oxygen Saturation During Gastric Tube Reconstruction With Cervical Anastomosis for Esophagectomy

  Kenjiro Ishii

DOTE Festival


DOTE.01 - Short- and Mid-Term Outcomes of Robotic Versus Thoraco-Laparoscopic McKeown Esophagectomy for Squamous Cell Esophageal Cancer: A Propensity Score-Matched Study

  Zhigang Li

DOTE.02 - Routine Placement of Feeding Jejunostomy Tube During Esophagectomy Increases Postoperative Complications and Does Not Improve Postoperative Malnutrition

  Yasufumi Koterazawa

DOTE.03 - Improved Barrett’s Neoplasia Detection Using Computer-Assisted Multiframe Analysis of Volumetric Laser Endomicroscopy

  Maarten Struyvenberg

DOTE.04 - Esophageal Oncologic Surgery in SARS-CoV-2 (COVID-19) Emergency

  Lavinia Barbieri

DOTE.05 - Transition From Video-Assisted Thoracoscopic to Robotic Esophagectomy: A Single Surgeon’s Experience

  Yin-Kai Chao

DOTE.06 - Persistent Confirmed Low-grade Dysplasia in Barrett's Esophagus Is a Risk Factor for Progression to High-grade Dysplasia and Adenocarcinoma in a US Veterans' Cohort

  Brian Hanson

PL13 - Updated Guidelines and Staging for Esophageal Cancer


  Magnus Nilsson   Yuko Kitagawa

PL13.01 - JES Surgical Guidelines for Locally Advanced ESCC: Contrasting Upfront Surgery With Neoadjuvant Therapy

  Yuko Kitagawa

PL13.02 - ESMO Guidelines for Locally Advanced Adenocarcinoma: When Should We Use Chemotherapy Versus Chemoradiation as Preoperative Therapy?

  Radka Obermannova

PL13.03 - Staging for Esophageal Cancer After Neoadjuvant Treatment: Is It Accurate and What Are the Best Parameters?

  Sheraz Markar

PL13.04 - TNM Staging for EGJ Tumors: Esophageal or Gastric, or Does It Matter?

  Wayne Hofstetter

PL13.05 - The TIGER Study: Time to Standardize Lymphadenectomy for Esophageal Cancer

  Suzanne Gisbertz

PL14 - Eosinophilic Esophagitis and Dysphagia


  Vani Konda   Varocha Mahachai

PL14.01 - Diagnosis of EoE: Symptoms, Endoscopy, Histology

  Gary Falk

PL14.02 - Pathophysiology and Epidemiology: Why Is EoE Rare in the East?

  Varocha Mahachai

PL14.03 - Medical Treatment Of Eosinophilic Esophagitis and Dysphagia: Current and Future Treatments

  Vani Konda

PL14.04 - Complications Of Eosinophilic Esophagitis and Dysphagia: Perforation, Stenosis and Food Impactions

  Roos Pouw

PL14.05 - Is There an Overlap Between EoE and GERD?

  Gary Falk

FA05 - Featured Abstracts 5


  Magnus Nilsson   Yin-Kai Chao

FA05.01 - Impact of Time to Surgery After Chemoradiotherapy on Tumor Regression and Survival in the Multicenter Randomized Controlled NeoRes II Trial

  Magnus Nilsson

FA05.02 - Survival Differences According to the Pathologic Status After Neoadjuvant Therapy Followed by Surgery in Esophageal Squamous Cell Carcinoma

  Seong Yong Park

FA05.03 - Detection of Molecular Residual Disease (MRD) Using Matched Tumor-margin Sequencing in Early Stage Esophageal Squamous Cell Carcinoma

  Di Lu

FA05.04 - Patterns of Recurrent Disease after Neoadjuvant Chemoradiotherapy and Esophageal Cancer Surgery with Curative Intent

  Nannet Schuring

FA05.05 - Intratumoral Microbiome Impacts Immune Infiltrates in Tumor Microenvironment and Predicts Prognosis in Esophageal Squamous Cell Carcinoma Patients

  Xuan Xie

FA05.06 - Recurrent Disease After Esophageal Cancer Surgery; a Substudy of the Dutch Nationwide Ivory Study

  Sofie Henckens

FA05.07 - Micronutrient Deficiencies after Gastroesophageal Cancer Surgery

  Lotte Blonk

FA05.09 - Totally Minimally Invasive 2-stage Esophagectomy versus Hybrid 2-stage Esophagectomy. A Single Center Experience

  Spyridon Davakis

VA03 - Video Abstracts 3


11:45 PM - 11:59 PM

VA03.02 - Bilateral Vocal Cord Paralysis After Hypopharyngeal Cervical Esophageal ESD – An Unrecognised Rare Complication

  Hon Chi Yip

VA03.03 - Laparoscopic Re Do Fundoplication

  Parthasarathi Ramakrishnan

VA03.04 - Oesophago-gastric Junction-plasty: Paraesophageal Hernia Repair + Anti Reflux Surgery Revisited

  Abraham Botha

VA03.05 - Utility of Endoluminal Functional Lumen Imaging in Diagnosis of Esophageal Dysfunction Following Bariatric Surgery

  Rebecca Yao

VA03.06 - Laparoscopic Repair of Esophageal Perforation

  Xin Yan Lim

VA03.08 - Thoracolaparoscopic Management of Esophageal Perforations

  Parthasarathi Ramakrishnan

VA03.09 - ICG Guided Thoracic Duct Clipping for Chyle Leaks

  Srijan Shukla

PL16 - Multidisciplinary Approaches and Perioperative Care of Esophagectomy (part 1)


  Donald E. Low   Lorenzo Ferri

PL16.01 - Detection of Residual Disease After Chemoradiotherapy; Results From European Pre-SANO (and SANO) Trial

  Bas Wijnhoven

PL15 - How to Find and Treat Neoplastic Barrett's Esophagus (part 1)


  Jacques Bergman   Sheila Krishnadath

PL15.01 - Defining Cancer Risk in Barrett’s Esophagus: Molecular or Expert Pathology

  Rebecca Fitzgerald

VS04 - Endoscopic, Surgical Resection Methods and Lymph Node Dissection (part 1)


  Simon Law   Yuko Kitagawa

VS04.01 - Intensive Mediastinal Lymph Node Dissection by VATS and RATS for Esophageal Cancer

  Hirofumi Kawakubo

FA06 - Featured Abstracts 6 (part 1)


  Fredrik Klevebro   Long-Qi Chen

FA06.02 - Patient-Derived Esophageal Adenocarcinoma Organoids Treated With Chemotherapeutic Agents May Predict Tumor Response In Vivo

  Jarlath Bolger

FA06.03 - Postoperative Chemoradiation for Local Advanced Esophageal Squamous Cell Carcinoma With Low Mean Platelet Volume

  Qifeng Wang

OA11 - Oral Abstracts 11 (part 1)


OA11.01 - Perioperative Outcome and Surgical Technique of Transmediastinal Esophagectomy for Esophagogastric Junction Cancer

  Atsushi Shiozaki

OA11.02 - The Role of Intraoperative Hyperspectral Imaging (HSI) in the Case of Using Colon Interposition after Oesophagectomy

  Yusef Moulla

OA11.03 - Results Comparing SAFE (Supercharged Cervical Anastomosis For Esophagectomy and Gastric Pull-up) and non-SAFE Procedure: Propensed Matched Score Study

  Flavio Roberto Takeda

OA11.04 - Esophagectomy for Esophageal and Gastroesophageal Junction Adenocarcinoma in RYGB Patients. A Literature Review on Operative Techniques, Safety and Oncologic Outcome

  Abdul-Rahman Diab

OA11.05 - Uniportal VATS McKeown Esophagectomy: 4-year Experience from a Tertiary Care Center

  Shiv Rajan

OA11.06 - Incidence of Reactive Hypoglycaemia in Disease Free Post-oesophagectomy Cohort

  Mistura Kareem

Thursday, September 29

12:00 AM - 01:15 AM

PL15 - How to Find and Treat Neoplastic Barrett's Esophagus (part 2)


  Jacques Bergman   Sheila Krishnadath

PL15.02 - Are There Any Agents to Prevent Progression in Barrett’s Esophagus

  Sheila Krishnadath

PL15.03 - Endoscopic Therapy for Barrett’s Esophagus: When to Resect, When to Burn?

  Neil Gupta

PL15.04 - What to Do When EMR Leaves Positive Margins: ESD or Full Thickness Resection?

  Kenneth Wang

PL15.05 - Artificial Intelligence in Barrett’s Esophagus

  Jacques Bergman

VS04 - Endoscopic, Surgical Resection Methods and Lymph Node Dissection (part 2)


  Simon Law   Yuko Kitagawa

VS04.02 - Hybrid Esophagectomy With Intraoperative Hyperspectral Imaging

  Ines Gockel

VS04.03 - Precise Mediastinal Lymph Node Dissection for Esophageal Cancer

  Riccardo Rosati

VS04.04 - Full Thickness Endoscopic Resection for Barrett's Cancer

  Kenneth Wang

VS04.05 - Tunneled Esophageal ESD

  Hironari Shiwaku

VS04.06 - Anastomotic/Reconstruction Techniques for Esophagectomy

  C S Pramesh

FA06 - Featured Abstracts 6 (part 2)


  Fredrik Klevebro   Long-Qi Chen

FA06.04 - A Validated Nomogram Predicting Lymph Node Metastasis of T2N0 Esophageal Squamous Cell Carcinoma for Clinical Decision-Making

  Yi-Min Gu

FA06.05 - Neoadjuvant Carboplatin/Paclitaxel Versus 5-Fluorouracil/Cisplatin in Combination With Radiotherapy for Esophageal Squamous Cell Carcinoma: A Multicenter Comparative Study

  Xing Gao

FA06.06 - Th1 Cell Is the Key Immune-associated Predictor of Pathological Complete Response Following Neoadjuvant Chemoradiation for Esophageal Squamous Cell Carcinoma

  Jianye Yuan

FA06.07 - Sonic Hedgehog Positive Expression is Associated with Prognosis and the Response of Esophageal Squamous Cell Carcinoma to Neoadjuvant Chemotherapy

  Haibo Sun

FA06.08 - Comparison of Recurrence Patterns and Survival after Neoadjuvant Chemoradiotherapy vs. Chemotherapy for Esophageal Cancer, a Multi-center European Cohort Study

  Fredrik Klevebro

FA06.09 - Clinical Value and Efficacy Index of Lymphadenectomy for Thoracic Esophageal Squamous Cell Carcinoma

  Kexun Li

OA11 - Oral Abstracts 11 (part 2)

OA11.07 - Effect of Endoluminal Vacuum Therapy on the Perfusion of Gastric Conduit in a Porcine Model for Esophagectomy

  Eleni Felinska

OA11.08 - Differences in Multidisciplinary Team Assessment on Esophageal Cancer Patients in Sweden – A Multicentre Study

  Christine Jestin Hannan

OA11.09 - Double Lumen Jejunal Free Flap Reconstruction after Proximal Esophageal Resection for Malignancy

  Geoffrey Chow


PL16 - Multidisciplinary Approaches and Perioperative Care of Esophagectomy (part 2)


  Donald E. Low   Lorenzo Ferri

01:30 AM - 03:00 AM

PL16.02 - Detection of Residual Disease After Chemoradiotherapy; Results From Asian Pre-SINO Trial

  Zhigang Li

PL16.03 - Fit For Surgery: Prehabilitation Routine for Esophagectomy

  Alexander Phillips

PL16.04 - ERAS Anesthetic Management

  Gabriel Mena

PL16.05 - Postop ERAS Protocol for Esophagectomy

  Donald E. Low

YI - Young ISDE


  David Liu   Jessie Elliott   Sheraz Markar

YI.01 - Building a Career in Translational Research

  Sheila Krishnadath

YI.02 - Developing Esophageal Clinical Trials in 2022

  David Watson

YI.03 - Creating the Next Generation of Allied Health Professional Researchers

  Emer Guinan

YI.04 - Establishing International Research Collaboratives

  Ewen Griffiths

PL17 - News on Diagnostics in Esophageal Motility


  Arjan Bredenoord   Mark Ferguson

PL17.01 - Approach to the Patient With Dysphagia in 2022

  Nicholas Shaheen

PL17.02 - Chicago 4.0: Changes in Definition of EGJOO

  Arjan Bredenoord

PL17.03 - HRM and How to Use Provocation Maneuvers and Consider Adjunct Testing

  Vani Konda

PL17.04 - Use of Endoflip in Esophageal Diagnostics

  John Pandolfino

PL17.05 - Use of Endoflip in Tailoring Fundoplication and Myotomy

  Silvana Perretta

03:00 AM - 03:30 AM

Closing Remarks


胸外医生 陆



  • 暂无相关文章!